Your browser doesn't support javascript.
loading
Dissecting the mechanism of cytokine release induced by T-cell engagers highlights the contribution of neutrophils.
Leclercq, Gabrielle; Servera, Llucia Alberti; Danilin, Sabrina; Challier, John; Steinhoff, Nathalie; Bossen, Claudia; Odermatt, Alex; Nicolini, Valeria; Umaña, Pablo; Klein, Christian; Bacac, Marina; Giusti, Anna-Maria; Schneider, Anneliese; Haegel, Hélène.
Afiliación
  • Leclercq G; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Servera LA; Department of Pharmaceutical Sciences, Division of Molecular and Systems Toxicology, University of Basel, Basel, Switzerland.
  • Danilin S; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Basel, Basel, Switzerland.
  • Challier J; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Basel, Basel, Switzerland.
  • Steinhoff N; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Bossen C; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Odermatt A; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Basel, Basel, Switzerland.
  • Nicolini V; Department of Pharmaceutical Sciences, Division of Molecular and Systems Toxicology, University of Basel, Basel, Switzerland.
  • Umaña P; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Klein C; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Bacac M; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Giusti AM; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Schneider A; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Haegel H; Roche Pharma Research and Early Development, pRED, Roche Innovation Center Zurich, Zurich, Switzerland.
Oncoimmunology ; 11(1): 2039432, 2022.
Article en En | MEDLINE | ID: mdl-35186442
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Citocinas / Anticuerpos Biespecíficos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncoimmunology Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Citocinas / Anticuerpos Biespecíficos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncoimmunology Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos